• 2022-07-28 问题

    Which of the following is not a Sub-discipline of pharmaceutics?( ) A: Physical pharmacy B: Industrial pharmacy C: Pharmacokinetics D: Clinical medicine

    Which of the following is not a Sub-discipline of pharmaceutics?( ) A: Physical pharmacy B: Industrial pharmacy C: Pharmacokinetics D: Clinical medicine

  • 2022-06-05 问题

    Clinical trial IV (四期临床实验) is ( ) A: focusing on the effects on body functions, dose definition, pharmacokinetics B: focusing on the effects on disease: safety, efficacy dose, pharmacokinetics C: focusing on effects about patient groups compared with standard therapy FDA approval D: long-term benefit- risk evaluation

    Clinical trial IV (四期临床实验) is ( ) A: focusing on the effects on body functions, dose definition, pharmacokinetics B: focusing on the effects on disease: safety, efficacy dose, pharmacokinetics C: focusing on effects about patient groups compared with standard therapy FDA approval D: long-term benefit- risk evaluation

  • 2022-07-28 问题

    Which<br/>of the following is not a Sub-discipline of pharmaceutics?( ) A: Physical pharmacy B: Industrial pharmacy C: Pharmacokinetics D: Clinical medicine

    Which<br/>of the following is not a Sub-discipline of pharmaceutics?( ) A: Physical pharmacy B: Industrial pharmacy C: Pharmacokinetics D: Clinical medicine

  • 2022-07-28 问题

    下列不属于pharmaceutics分支学科的是( )。 A: physical pharmaceutics B: 生物化学 C: industrial pharmaceutics D: pharmacokinetics E: clinical pharmaceutics

    下列不属于pharmaceutics分支学科的是( )。 A: physical pharmaceutics B: 生物化学 C: industrial pharmaceutics D: pharmacokinetics E: clinical pharmaceutics

  • 2022-06-14 问题

    In the study of pharmacokinetics and bioavailability, LLOQ should be able to determine the drug concentration in biosamples at 3-5 elimination half-lives after dosing or within the range of 1/5 to 1/2 of the Cmax.

    In the study of pharmacokinetics and bioavailability, LLOQ should be able to determine the drug concentration in biosamples at 3-5 elimination half-lives after dosing or within the range of 1/5 to 1/2 of the Cmax.

  • 2022-05-27 问题

    群体药物动力学模型(population Pharmacokinetics, PPK)是指经典药物动力学模型与群体统计模型相结合,研究药物吸收和配置的群体规律的一种新的药物动力学分支学科。

    群体药物动力学模型(population Pharmacokinetics, PPK)是指经典药物动力学模型与群体统计模型相结合,研究药物吸收和配置的群体规律的一种新的药物动力学分支学科。

  • 2022-05-27 问题

    群体药物动力学模型(population Pharmacokinetics, PPK)是指经典药物动力学模型与群体统计模型相结合,研究药物吸收和配置的群体规律的一种新的药物动力学分支学科。 A: 正确 B: 错误

    群体药物动力学模型(population Pharmacokinetics, PPK)是指经典药物动力学模型与群体统计模型相结合,研究药物吸收和配置的群体规律的一种新的药物动力学分支学科。 A: 正确 B: 错误

  • 1